StayHappi Nebivolol HCl + Chlorthalidone Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is typically used for the treatment of High BP, Edema, High BP. Secondary and off-label uses of StayHappi Nebivolol HCl + Chlorthalidone Tablet have also been mentioned below.
The correct dosage of StayHappi Nebivolol HCl + Chlorthalidone Tablet depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
StayHappi Nebivolol HCl + Chlorthalidone Tablet also has some side effects, the most common being Dizziness, Loss of appetite, Gastric Irritation. While these are the most often observed StayHappi Nebivolol HCl + Chlorthalidone Tablet side effects, there are can be others also. These have been listed below. Normally, these side effects of StayHappi Nebivolol HCl + Chlorthalidone Tablet are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, StayHappi Nebivolol HCl + Chlorthalidone Tablet's effect is Severe during pregnancy and Severe for lactating mothers. In addition, StayHappi Nebivolol HCl + Chlorthalidone Tablet's effects on the liver, heart and kidney are discussed below in the StayHappi Nebivolol HCl + Chlorthalidone Tablet related warnings section.
Individuals suffering from medical conditions like Liver Disease, Kidney Disease, Diabetes must refrain from the use of StayHappi Nebivolol HCl + Chlorthalidone Tablet since this can cause severe adverse effects. Other conditions have been mentioned below in the StayHappi Nebivolol HCl + Chlorthalidone Tablet contraindications section.
Drug interactions for StayHappi Nebivolol HCl + Chlorthalidone Tablet have been reported in the medical literature. Refer to the list below for further details.
In addition to the above precautions for StayHappi Nebivolol HCl + Chlorthalidone Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
StayHappi Nebivolol HCl + Chlorthalidone Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of StayHappi Nebivolol HCl + Chlorthalidone Tablet safe for pregnant women?
Pregnant women may get severe side effects after taking StayHappi Nebivolol HCl + Chlorthalidone Tablet. If you are pregnant, do not take StayHappi Nebivolol HCl + Chlorthalidone Tablet without a doctor's advice.
Is the use of StayHappi Nebivolol HCl + Chlorthalidone Tablet safe during breastfeeding?
Taking StayHappi Nebivolol HCl + Chlorthalidone Tablet may lead to serious side effects if you are breastfeeding. StayHappi Nebivolol HCl + Chlorthalidone Tablet should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of StayHappi Nebivolol HCl + Chlorthalidone Tablet on the Kidneys?
StayHappi Nebivolol HCl + Chlorthalidone Tablet rarely affects the kidneys.
What is the effect of StayHappi Nebivolol HCl + Chlorthalidone Tablet on the Liver?
Very few cases of side effects of StayHappi Nebivolol HCl + Chlorthalidone Tablet on the liver have been reported.
What is the effect of StayHappi Nebivolol HCl + Chlorthalidone Tablet on the Heart?
StayHappi Nebivolol HCl + Chlorthalidone Tablet is rarely harmful for the heart.
StayHappi Nebivolol HCl + Chlorthalidone Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take StayHappi Nebivolol HCl + Chlorthalidone Tablet unless your doctor advises you to do so -
Is this StayHappi Nebivolol HCl + Chlorthalidone Tablet habit forming or addictive?
Forming a habit of StayHappi Nebivolol HCl + Chlorthalidone Tablet has not been reported.
Interaction between Food and StayHappi Nebivolol HCl + Chlorthalidone Tablet
Some foods when eaten with StayHappi Nebivolol HCl + Chlorthalidone Tablet can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and StayHappi Nebivolol HCl + Chlorthalidone Tablet
Consuming StayHappi Nebivolol HCl + Chlorthalidone Tablet with alcohol can have many serious effects on your body.
StayHappi Nebivolol HCl + Chlorthalidone Tablet works by increasing the rate of urine formation by inhibiting the sodium and potassium reabsorption in the kidney, this causes more frequent urination than normal. The increased flow of urination leads to a decrease in blood volume that helps in the relaxation of the walls of blood vessels and this results in a decrease in blood pressure.
Yes, StayHappi Nebivolol HCl + Chlorthalidone Tablet may cause hair loss. If you are experiencing severe hair loss after taking this drug, you are advised to consult it with your doctor.
No, StayHappi Nebivolol HCl + Chlorthalidone Tablet should not be discontinued without doctors advice. You are recommended to always consult a doctor before discontinuing this medicine.
Yes, StayHappi Nebivolol HCl + Chlorthalidone Tablet is safe to use, if taken in prescribed amount and duration as advised by the doctor. However, certain side effects have been associated with this drug such as diarrhea, headache, and dizziness. If you experience any discomfort after taking this do inform your doctor.
Yes, StayHappi Nebivolol HCl + Chlorthalidone Tablet may cause weight loss. If you are experiencing the same after taking this drug, you are advised to consult it with your doctor.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Thalitone ® (chlorthalidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 583-584
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Bystolic® (nebivolol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149-151
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 896-897